Prospeo
Hero Section BackgroundHero Section Background
RevBio

RevBio Revenue

Medical Equipment ManufacturingFlag of USLowell, Massachusetts, United States21-50 Employees

$

RevBio revenue & valuation

Annual revenue$5,500,000
Revenue per employee$172,000
Estimated valuation?$17,600,000
Total funding$4,400,000

Key Contacts at RevBio

Flag of US

Grayson Allen

Cfo/Coo & Co-Founder

Flag of US

Michael Tiedemann

Chief Marketing Officer

Flag of US

Brian Hess

Ceo And Founder

Flag of US

George W. Kay

Co-Founder And Chief Scientific Officer

Flag of US

Gary Bunnewith

Director Of Quality

Flag of US

Alan Pollack

Senior Director Dental Clinical Operations

Company overview

Headquarters600 Suffolk Street, Suite 250, Lowell, MA 01854, US
Phone number+16179476246
Website
NAICS3391
SIC384
Keywords
Biomaterials, Dental, Orthopaedics, Innovation, Medical Device, Oral Surgery, Adhesive, Neurosurgery, Veterinary Medicine, Therapeutics, Trauma, Musculoskeletal, Spine, Biologics, Regenerative Medicine, Periodontics, Bone, Fracture Repair, Bone Graft, Biomimetics
Founded2014
Employees21-50
Socials

RevBio Email Formats

RevBio uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@revbio.com), used 70.8% of the time.

FormatExamplePercentage
{first initial}{last name}
jdoe@revbio.com
70.8%
{first name}{last name}
johndoe@revbio.com
29.2%

About RevBio

RevBio was started with one goal in mind—to end medicine’s 50 year search for a biocompatible bone adhesive. Effective for bone-to-bone as well as bone-to-metal wet field applications, Tetranite® is a revolutionary biomaterial that promises to transform bone repair—for both patients and clinicians. Inspired by the marine animal the sandcastle worm, Tetranite is simple chemistry. Bioengineered from the worm’s secreted protein, our synthetic adhesive is the only patented biomaterial which satisfies both the required and desired properties for a bone adhesive: wet field performance, multi-surface bonding, rapid mechanical stability, and controlled biodegradability. The properties of Tetranite™ include the ability to provide immediate fixation of bone to bone and bone to metal. This adhesive has been shown in multiple animal studies to be a non-toxic and effective way of repairing bone fractures and defects as well as securing implant devices. Existing data has also shown that Tetranite™ is reabsorbed and replaced with new bone during the natural process of bone remodeling by acting as a scaffold to facilitate bone growth over time.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry
C-Suite
Senior

Employees by Department

RevBio has 23 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore RevBio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2023-11-259$2,000,000
2024-10-169$2,400,000

Funding Insights

$4,400,000

Total funding amount

$2,400,000

Most recent funding amount

2

Number of funding rounds

RevBio Tech Stack

Discover the technologies and tools that power RevBio's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

reCAPTCHA

Security

Jetpack

Jetpack

WordPress plugins

Gravity Forms

Gravity Forms

Form builders

Site Kit

Site Kit

Analytics

Swiper

Swiper

JavaScript libraries

Microsoft 365

Microsoft 365

Email

jQuery Migrate

jQuery Migrate

JavaScript libraries

Cloudflare

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

jQuery

JavaScript libraries

HubSpot Analytics

HubSpot Analytics

Analytics

HTTP/3

HTTP/3

Miscellaneous

Frequently asked questions

RevBio is located in Lowell, Massachusetts, US.
You can reach RevBio at +16179476246.
RevBio generates an estimated annual revenue of $5,500,000. This revenue figure reflects the company's market position and business performance in its industry.
RevBio has an estimated valuation of $17,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
RevBio was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.
RevBio has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
RevBio has raised a total of $4,400,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles